Treatment with anti-interleukin-10 monoclonal antibody enhances early resistance to but impairs complete clearance of Listeria monocytogenes infection in mice.
Mice that received an anti-interleukin-10 (anti-IL-10) neutralizing monoclonal antibody (MAb) (SXC-1) prior to infection with Listeria monocytogenes initially demonstrated resistance to the infection, as indicated by reduced recovery of L. monocytogenes from their spleens and livers during the first...
Gardado en:
| Publicado en: | Infect Immun |
|---|---|
| Principais autores: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
American Society for Microbiology (ASM)
1994
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC186517/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8188357/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/iai.62.6.2345-2353.1994 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|